Clinical trial Recruiting at 1 site Observational Ages 18 and up Women only

How ultrafine particles and micro‑nano plastics affect fetal development

Official title: UPRISE Unravelling Ultrafine Particulate Matter and Micro Nano Plastic's Mechanisms of Impact on Fetal Health

Run by Instituto de Investigacion Sanitaria La Fe · NCT07238608 · Data updated 2026-11-12

This project will test whether pregnant women’s exposure to ultrafine particulate matter and micro‑nano plastics increases the chance of preterm birth and later non‑communicable diseases in their children.

Quick facts

Study typeObservational
Ages18 Years and up
SexWomen only
Enrollment1600 (estimated)
SponsorInstituto de Investigacion Sanitaria La Fe
Academic / other
Locations1 site (Valencia, Valencia)
StatusRecruiting
StartedJanuary 1, 2026
Main results expectedDecember 31, 2029
Study endsDecember 31, 2029
Registry record updatedNovember 20, 2025
Trial IDNCT07238608 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are non‑smoking pregnant women aged 18 or older who have lived in the study area for at least one year and can enroll early in pregnancy.

Probably not a fit

Women who smoke, have multiple pregnancies, known kidney disease, late presentation after the first trimester, or who plan to terminate the pregnancy are unlikely to benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is an observational case‑control study of 1,600 newborns comparing preterm and full‑term births, with a 1:2 control ratio in participating countries. A nested personal exposure monitoring substudy will equip 150 pregnant mothers (50 per location) with sensors to measure individual ultrafine particle and micro‑plastic exposure and collect biological samples including urine. Participants are non‑smoking women aged 18 or older who have lived in the study area at least one year and enroll early in pregnancy; exclusions include multiple pregnancy, known kidney disease, significant pregnancy complications, or late first visit. Data will be used to link measured exposures in pregnancy to timing of delivery and early‑life markers that may predispose to later non‑communicable diseases.

Why it matters

Potential benefit: If successful, the project could identify specific prenatal exposures that raise preterm birth risk and support actions to reduce exposure during pregnancy to improve child health.

How similar studies have gone: Prior epidemiological work has linked general air pollution (PM2.5/PM10) to preterm birth, but the specific roles of ultrafine particles and micro‑nano plastics are less established and personal exposure monitoring in pregnancy remains relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Agreement to sign the informed consent;
* Non-smoking mothers and no exposure to environmental (second-hand) smoke (smoking influences UFP measurements);
* ≥18 years old (mothers have to place sensors, mothers with childhood pregnancies may live at their parental home);
* Not expecting to terminate the pregnancy (no measurements of the child);
* Having resided in the geographical area of research for a minimum period of 1 year (to be eligible for modeling exposures).

Exclusion Criteria:

* First visit after 11 weeks of gestation (to ensure 2-week monitoring in the first trimester);
* Pregnancy complications that limit exposure measurements in urine (because it may cause polyuria, for example, gestational diabetes);
* Known kidney disease (might influence exposure measurements in urine);
* Multiple pregnancy (twin or more pregnancies may have a higher risk for complications or preterm birth, no measurements in the last trimester).

Where it's running

  • Instituto de Investigación Sanitaria La Fe
    Valencia, Valencia, Spain
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.